Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$945K Buy
+59,500
New +$922K ﹤0.01% 2873
2024
Q2
Sell
-66,500
Closed -$794K 2500
2024
Q1
$794K Sell
66,500
-22,700
-25% -$273K ﹤0.01% 1522
2023
Q4
$966K Hold
89,200
﹤0.01% 1407
2023
Q3
$880K Buy
89,200
+72,000
+419% +$750K ﹤0.01% 1366
2023
Q2
$172K Hold
17,200
﹤0.01% 1464
2023
Q1
$165K Buy
17,200
+1,800
+12% +$20K ﹤0.01% 1534
2022
Q4
$171K Buy
+15,400
New +$161K ﹤0.01% 1274
2022
Q2
Sell
-1,565,600
Closed -$17M 1656
2022
Q1
$17M Buy
1,565,600
+599,900
+62% +$7.9M 0.07% 368
2021
Q4
$13.1M Buy
+965,700
New +$12.9M 0.05% 438
2017
Q2
Sell
-40,000
Closed -$1.56M 1012
2017
Q1
$1.56M Buy
+40,000
New +$1.61M 0.01% 697
2016
Q1
Sell
-1,000,000
Closed -$54.1M 858
2015
Q4
$54.1M Hold
1,000,000
0.45% 56
2015
Q3
$40.3M Buy
+1,000,000
New +$55.8M 0.32% 96

Other funds holding VTRS

Steven Cohen's VTRS Position: Q2 2026 in Review

Steven Cohen reduced its Viatris (VTRS) stake by 68% in Q2 2026, selling an estimated $18.8M and leaving 563,129 shares worth $8.94M. The position accounts for 0.01% of the portfolio, ranked #1351.

Steven Cohen first reported a position in VTRS in Q2 2014 and has held it in 33 quarters since. The position peaked at $170M in Q4 2017. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Steven Cohen held 563,129 shares of Viatris worth $8.94M as of Q2 2026.
  • Steven Cohen sold 1,214,052 Viatris shares in Q2 2026, an estimated $18.8M.
  • Viatris made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1351 holding.
  • Steven Cohen first reported a position in Viatris in Q2 2014 and has held it in 33 quarters since.
  • Steven Cohen's Viatris position peaked at $170M in Q4 2017.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.